July 9, 2020 Price forecast | 2 weeks: -0.08% | 1 month: 0.32% | 3 months: 3.37%

LLY stock forecast

Our latest prediction for Eli Lilly & Co.'s stock price was made on the July 9, 2020 when the stock price was at 166.45$.

In the short term (2weeks), LLY's stock price should underperform the market by -0.08%. During that period the price should oscillate between -4.33% and +3.27%.

In the medium term (3months), LLY's stock price should outperform the market by 3.37%. During that period the price should oscillate between -11.23% and +9.86%.

Create a solid portfolio with LLY

Add LLY to your portfolio and optimize it!

About Eli Lilly & Co.

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

At the moment the company generates 23087M USD in revenues.

On its last earning announcement, the company reported a profit of 6.18$ per share.

The book value per share is 10.76$

Eli Lilly & Co. website

Three months stock forecastJuly 9, 2020


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
23087M 79.20% 6132M 26.60% 5533M 6.18 2.67 - 918M 10.76 4907M -1224M 3684M